Gold Laboratory
The Gold lab explores neurocognitive changes associated with human aging. We study the effects of structural and functional brain changes on cognition in aging and age-related disorders such as Alzheimer’s disease. In addition, we study the effects of lifestyle variables (e.g., exercise, cognitive stimulation) on brain aging.
NIH FY2014 Fiscal Policy
Non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2014 likely will be made within the range between the commitment level indicated on the Notice of Award and 3 percent below that level.
The NIH awarding Institutes/Centers (IC) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2014 funds.
2014 Annual Survey of Select Agent and Toxin Usage
Sent on behalf of Brandy Nelson, University of Kentucky Biosafety Officer and Responsible Official:
Per the Code of Federal Regulations (7 CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73) possession, use or transfer of the infectious agents and toxins listed below requires registration with the Centers for Disease Control and Prevention and/or United States Department of Agriculture. Non-compliance with these regulations may result in criminal penalties, including fines and incarceration, affecting the University of Kentucky and/or the individual in possession of the material.
UK HealthCare Designated a Comprehensive Stroke Center by The Joint Commission
UK HealthCare has been designated a Comprehensive Stroke Center by The Joint Commission (TJC) and the American Heart Association/American Stroke Association.
UK HealthCare is one of 63 U.S. institutions and the only in Lexington to be awarded this designation, which is the highest honor The Joint Commission awards to stroke centers.
stroke_center_designation-19_1_0.jpg
UK College of Medicine Student Receives Fellowship Award
University of Kentucky College of Medicine student Melanie Pleiss has received the PhRMA Foundation Pre-Doctoral Fellowship in Pharmacology/Toxicology.
The fellowship is a two year award that provides recipients with an annual stipend of $20,000 to support the research activities of a doctoral program.
"The application process is extremely competitive, with just one applicant per institution allowed to apply and only a certain number of awards given to U.S. schools of medicine, pharmacy, dentistry or veterinary medicine," said Dr.
lab_picture.jpg
Markey Now Offers Unique Varian Truebeam Radiation Therapy
The University of Kentucky Markey Cancer Center has become one of the first cancer centers in the country to offer the latest model of the Varian TrueBeam for its patients.
The Varian TrueBeam is an advanced radiotherapy system from Varian Medical Systems, designed to deliver powerful cancer treatments with pinpoint accuracy and precision.
tb-beauty_shot_front-no_couch.jpg
NIH Releases Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2014
Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2014
KL2 Program Creates Momentum for Junior Faculty and UK's Research Enterprise
For junior faculty with clinical and/or teaching responsibilities, it's difficult to find enough time to prioritize their own research. On top of time constraints, junior faculty members often have limited experience in the precise art of writing successful federal grant applications and managing large grants. It takes time, training, and funding to accelerate a research career. The KL2 Career Development Program provides these resources to investigators to do just that.
fornwalt_vandsburger_leung_uknow1.jpg
New UK Study Shows Potential for Targeting Aggressive Breast Cancers
A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.
Triple-negative breast cancer has an activated EMT program, which is a process that provides cells with the increased plasticity (or flexibility) to adapt to stressed environments during embryonic development, wound healing, tissue fibrosis and metastasis.
zhou.jpg